Machine-learning algorithms tuned to detecting cancer DNA in the blood could pave the way for personalized cancer care.
copyright by www.the-scientist.com
Modern cancer medicine is hampered by two big challenges—detecting cancers when they are small and offering cancer patients personalized, dynamic cancer care. To find solutions, several academic labs and biotech firms are turning to artificial intelligence, working to develop machine-learning algorithms that could help decipher weak signals in the blood that can identify cancers at an early stage and indicate whether a cancer is responding to treatment in real time.
“You have to find this needle in a haystack . . . this very weak signal amongst all of the cacophony of everything else happening in the body,” says Dave Issadore , a bioengineer at Pennsylvania State University and founder of Chip Diagnostics, which is developing a machine-learning method to diagnose disease by sequencing extracellular vesicles’ cargo.
So far, machine-learning algorithms designed to detect minute quantities of tumor DNA in a blood sample—the goal of so-called liquid biopsies—have performed well in clinical validation studies, but no self-learning algorithm has yet been approved for clinical use. These have the potential to outperform imaging and tissue biopsies in detecting and monitoring cancers by looking for mutations in DNA, RNA, and proteins directly from the blood.
“I think the dream of liquid biopsy is to, A), detect cancer when there is very little of it, and, B) detect cancers during treatment,” says Dan Landau, a clinical oncologist and researcher at Weill Cornell Medical School in New York. However, in the both contexts, liquid biopsy techniques struggle to accurately detect cancer among the infinitesimally small quantities of tumor nucleic acids in the blood. Although the technique’s performance varies between cancer types, liquid biopsies so far have been able to detect cancer in around half of early-stage patients diagnosed through imaging, giving it a sensitivity of just 50 percent.
Image Credit: The Scientist
News This Week
A pea-sized device used to seal tiny but potentially deadly holes in the hearts of premature infants has been approved by U.S. regulators, making it one of the smallest complex medical devices ever invented [...]
Scientists have discovered that squamous cell skin cancers do not require increased glucose to power their development and growth, contrary to a long-held belief about cancer metabolism. The findings could bring about a better [...]
Nanotechnology may well be one of the most talked about industries of the last few years. Predicted to value US$173.95 billion globally by 2025, this fast-moving sector is already delivering major sustainability, health and well-being benefits to society. [...]
Catalysts are chemical matchmakers: They bring other chemicals close together, increasing the chance that they’ll react with each other and produce something people want, like fuel or fertilizer. Since some of the best catalyst [...]
In a first-of-its-kind study, researchers used an ingenious experimental setup and high-energy X-ray beams to observe a high-temperature, high-pressure chemical reaction to establish how the formation of two varied nanoscale crystalline structures in the [...]